 |
|  |
Nov-13-19 | Initiated |
BofA/Merrill |
Neutral |
$51 |
|
Dec-13-18 | Initiated |
Berenberg |
Buy |
$55 |
|
May-31-18 | Initiated |
RBC Capital Mkts |
Outperform |
$65 |
|
Mar-21-18 | Upgrade |
Needham |
Hold → Buy |
$60 |
|
Mar-20-18 | Reiterated |
JMP Securities |
Mkt Outperform |
$63 → $79 |
|
Jan-18-18 | Resumed |
Credit Suisse |
Outperform |
$44 |
|
Jan-18-18 | Initiated |
Credit Suisse |
Outperform |
$44 |
|
Jan-03-18 | Upgrade |
Wells Fargo |
Market Perform → Outperform |
|
|
Jul-11-17 | Reiterated |
Citigroup |
Buy |
$23 → $37 |
|
Jul-07-17 | Upgrade |
JMP Securities |
Mkt Perform → Mkt Outperform |
|
|
Jun-27-17 | Initiated |
Citigroup |
Buy |
$23 |
|
May-19-17 | Initiated |
Leerink Partners |
Outperform |
$5 |
|
Sep-15-16 | Initiated |
FBR & Co. |
Outperform |
$6 |
|
Mar-01-16 | Reiterated |
RBC Capital Mkts |
Sector Perform |
$2 → $1.50 |
|
Nov-11-15 | Reiterated |
RBC Capital Mkts |
Sector Perform |
$5 → $2 |
|
Oct-28-15 | Reiterated |
WallachBeth |
Buy |
$6 → $4 |
|
May-12-15 | Reiterated |
WallachBeth |
Buy |
$8 → $6 |
|
Jan-23-15 | Initiated |
RBC Capital Mkts |
Sector Perform |
$5 |
|
Aug-07-14 | Reiterated |
WallachBeth |
Buy |
$9 → $8 |
|
Nov-15-13 | Initiated |
WallachBeth |
Buy |
$9 |
|
|
 |
Dec-13-19 02:31PM | The MLB allows players to smoke marijuana Yahoo Finance Video |
Dec-03-19 04:35PM | Hedge Funds Are Done Buying Arena Pharmaceuticals, Inc. (ARNA)? Insider Monkey |
Nov-27-19 06:34PM | Edited Transcript of ARNA earnings conference call or presentation 7-Nov-19 9:30pm GMT Thomson Reuters StreetEvents |
Nov-26-19 08:30AM | Arena Pharmaceuticals to Participate in Upcoming Investor Conferences PR Newswire |
Nov-18-19 04:01PM | California Life Sciences Association Honors Arena Pharmaceuticals at the Pantheon 2019 DiNA Awards for the Deal of the Year PR Newswire |
Nov-14-19 09:00AM | Everest Medicines Achieved First Patient Dosing Milestone in Etrasimod Phase 3 Clinical Study in Ulcerative Colitis Patients in Asia GlobeNewswire |
Nov-10-19 07:43AM | Can You Imagine How Chuffed Arena Pharmaceuticals's (NASDAQ:ARNA) Shareholders Feel About Its 189% Share Price Gain? Simply Wall St. |
Nov-08-19 08:56AM | Arena Pharmaceuticals' (ARNA) Q3 Loss Widens, Revenues Beat Zacks |
Nov-07-19 04:01PM | Arena Reports Third Quarter Financial Results with Continued Progress on Clinical Programs PR Newswire |
Nov-06-19 08:30AM | Arena Pharmaceuticals Presented New Data Highlighting the Human Mass Balance and Metabolism Profile of Etrasimod at AAPS PR Newswire |
Nov-05-19 05:41PM | Arena Pharmaceuticals to Present at Upcoming Investor Conferences PR Newswire |
Oct-31-19 11:45AM | United Therapeutics (UTHR) Q3 Earnings & Sales Top, Stock Up Zacks |
08:30AM | Arena Pharmaceuticals to Release Third Quarter 2019 Financial Results and Provide Corporate Update on November 7 PR Newswire |
Oct-28-19 08:30AM | Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis PR Newswire |
Oct-26-19 06:01PM | Top Marijuana Stocks on the NASDAQ Investopedia |
Oct-23-19 01:26PM | Hedge Funds Have Never Been This Bullish On Arena Pharmaceuticals, Inc. (ARNA) Insider Monkey |
Oct-22-19 04:01PM | Arena Pharmaceuticals Presented New Data Analyses Demonstrating the Long-Term Safety and Efficacy of Once-Daily Etrasimod in Patients with Moderately to Severely Active Ulcerative Colitis at UEG Week PR Newswire |
Oct-18-19 03:01AM | Arena Pharmaceuticals' Presence at United European Gastroenterology Week Bolsters Commitment to the Gastrointestinal Disease Community PR Newswire |
Oct-05-19 09:51AM | What Kind Of Shareholder Owns Most Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Stock? Simply Wall St. |
Sep-26-19 08:30AM | Arena Pharmaceuticals Presented New Data from the Phase 2 OASIS trial for Etrasimod at the World Congress of Gastroenterology Meeting PR Newswire -6.14% |
Sep-25-19 08:30AM | Arena Pharmaceuticals to Present at the Cantor Global Healthcare Conference on October 2 PR Newswire |
Sep-17-19 08:30AM | Arena Pharmaceuticals to Present New Preclinical Atopic Dermatitis Data for Etrasimod at the European Society for Dermatologic Research Annual Meeting PR Newswire |
Sep-12-19 11:25AM | United Therapeutics' Trevyent NDA for PAH Accepted by FDA Zacks |
Sep-10-19 11:15PM | Arena Pharmaceuticals Inc (ARNA) EVP, General Counsel & Sec Steven W Spector Sold $2. ... GuruFocus.com |
Sep-09-19 08:30AM | Arena Pharmaceuticals Presented New Patient-Reported Outcomes Data for Olorinab at the European Society of Neurogastroenterology & Motility NeuroGASTRO 2019 Meeting PR Newswire |
Sep-05-19 11:23AM | Does Arena Pharmaceuticals, Inc.'s (NASDAQ:ARNA) CEO Salary Compare Well With Others? Simply Wall St. |
Aug-28-19 08:30AM | Arena Pharmaceuticals to Participate in Upcoming Investor Conferences PR Newswire |
Aug-13-19 12:44PM | 25 Biggest Marijuana Companies in the World Insider Monkey |
Aug-08-19 04:47PM | Edited Transcript of ARNA earnings conference call or presentation 7-Aug-19 8:30pm GMT Thomson Reuters StreetEvents -7.77% |
04:08PM | This Biotech Crashed On 'Erroneous' Report Plus 2 Stocks That Diverged Investor's Business Daily |
10:34AM | Arena Pharmaceuticals' (ARNA) Q2 Loss Widens, Revenues Meet Zacks |
04:23AM | Arena Pharmaceuticals Inc (ARNA) Q2 2019 Earnings Call Transcript Motley Fool |
Aug-07-19 04:01PM | Arena Reports Second Quarter Financial Results with Strong Liquidity Position, and Initiation of Etrasimod ELEVATE UC 52 and Olorinab CAPTIVATE Trials PR Newswire |
Aug-06-19 03:50PM | Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) A High Quality Stock To Own? Simply Wall St. |
Aug-01-19 09:49AM | United Therapeutics (UTHR) Q2 Earnings & Sales Beat, Down Y/Y Zacks |
Jul-31-19 08:30AM | Arena Pharmaceuticals to Release Second Quarter 2019 Financial Results and Provide Corporate Update on August 7 PR Newswire |
Jul-29-19 10:34AM | Analysts Estimate Arena Pharmaceuticals (ARNA) to Report a Decline in Earnings: What to Look Out for Zacks |
Jul-25-19 09:00AM | Arena Pharmaceuticals (ARNA) Upgraded to Buy: Here's Why Zacks |
08:30AM | Arena Pharmaceuticals Announces First Subject Dosed in CAPTIVATE Phase 2 Trial Evaluating Olorinab in Abdominal Pain Associated with Irritable Bowel Syndrome PR Newswire |
Jul-09-19 01:32PM | Should Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Be Your Next Stock Pick? Simply Wall St. |
Jun-18-19 12:30PM | A Company's First Profit Can Mean Big Profits for Investors Zacks |
10:38AM | Arena Initiates Dosing in Pivotal Colitis Study on Etrasimod Zacks |
Jun-17-19 08:30AM | Arena Pharmaceuticals Announces First Subject Dosed in ELEVATE UC 52 Global Phase 3 Trial Evaluating Etrasimod in Ulcerative Colitis PR Newswire |
Jun-14-19 06:29PM | Did Hedge Funds Drop The Ball On Arena Pharmaceuticals, Inc. (ARNA) Insider Monkey |
Jun-13-19 06:29PM | Edited Transcript of ARNA earnings conference call or presentation 8-May-19 8:30pm GMT Thomson Reuters StreetEvents |
08:30AM | Arena Pharmaceuticals to Present at JMP Securities Life Sciences Conference on June 19 PR Newswire |
Jun-07-19 09:30AM | Why Is Arena Pharmaceuticals (ARNA) Up 9.1% Since Last Earnings Report? Zacks |
Jun-06-19 12:32PM | Does Market Volatility Impact Arena Pharmaceuticals, Inc.'s (NASDAQ:ARNA) Share Price? Simply Wall St. |
May-21-19 07:30AM | Corvidia Therapeutics Announces Dr. Preston Klassen Joins its Board of Directors PR Newswire |
May-17-19 08:30AM | Arena Pharmaceuticals' Presence at Digestive Disease Week (DDW) Reinforces Commitment to the Gastrointestinal Disease Community PR Newswire |
May-13-19 09:00AM | All You Need to Know About Arena Pharmaceuticals (ARNA) Rating Upgrade to Buy Zacks -6.14% |
08:30AM | Arena Pharmaceuticals to Participate in Upcoming Investor Conferences PR Newswire |
May-10-19 07:45PM | Arena Pharmaceuticals Inc (ARNA) Q1 2019 Earnings Call Transcript Motley Fool |
07:04AM | Did Business Growth Power Arena Pharmaceuticals's (NASDAQ:ARNA) Share Price Gain of 226%? Simply Wall St. |
May-09-19 04:24PM | S&P 500, Nasdaq end lower for fourth day after Trump claims China broke the deal MarketWatch |
09:03AM | Arena Pharmaceuticals' (ARNA) Loss Widens in Q1 But Stock Up Zacks |
May-08-19 04:46PM | Arena Pharmaceutical shares slide after drug maker reports disappointing financial results MarketWatch |
04:01PM | Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2019 Financial Results PR Newswire |
May-02-19 09:26AM | United Therapeutics (UTHR) Down Despite Q1 Earnings Beat Zacks |
May-01-19 08:30AM | Arena Pharmaceuticals to Release First Quarter 2019 Financial Results and Provide Corporate Update on May 8 PR Newswire |
Apr-30-19 02:50PM | Heres What Hedge Funds Think About Arena Pharmaceuticals, Inc. (ARNA) Insider Monkey |
Apr-24-19 11:30AM | The New Cannabis ETF Is Already Making Additions Benzinga |
Apr-03-19 11:52AM | What Type Of Shareholder Owns Arena Pharmaceuticals, Inc.'s (NASDAQ:ARNA)? Simply Wall St. |
08:30AM | Arena Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference on April 10 PR Newswire |
Mar-28-19 09:30AM | Why Is Arena Pharmaceuticals (ARNA) Down 10.1% Since Last Earnings Report? Zacks |
Mar-26-19 07:30AM | New Research Coverage Highlights The Blackstone Group, Arena Pharmaceuticals, Arrow Electronics, AdvanSix, KBR, and RPM International Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire |
Mar-18-19 03:36PM | These 3 Cannabis Stocks Are Set to Skyrocket, Say Analysts SmarterAnalyst |
Mar-08-19 08:30AM | Arena Pharmaceuticals Presented New Phase 2 Data for Etrasimod and Olorinab at the 14th Congress of European Crohn's and Colitis Organisation PR Newswire |
Mar-01-19 06:55AM | Edited Transcript of ARNA earnings conference call or presentation 26-Feb-19 9:30pm GMT Thomson Reuters StreetEvents |
Feb-28-19 10:16AM | United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates Zacks |
Feb-27-19 08:25AM | Arena Pharmaceuticals (ARNA) Beats on Q4 Earnings & Revenues Zacks |
Feb-26-19 08:52PM | Arena Pharmaceuticals Inc (ARNA) Q4 2018 Earnings Conference Call Transcript Motley Fool |
04:01PM | Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results PR Newswire |
Feb-25-19 03:25PM | 5 Clinical-Stage Biotech Stocks to Buy InvestorPlace |
Feb-21-19 08:30AM | Arena Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference on February 27 PR Newswire |
Feb-20-19 04:01PM | Arena Pharmaceuticals to Announce Fourth Quarter and Full-Year 2018 Financial Results and Provide Corporate Update on February 26 PR Newswire |
Feb-15-19 09:05AM | Top 3 Marijuana Stocks on the NASDAQ Investopedia |
Feb-07-19 04:30PM | Arena Pharmaceuticals Presents Preclinical and Early Clinical Development Data for Olorinab at Crohn's & Colitis Congress PR Newswire |
Jan-30-19 10:23AM | Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) A Financially Strong Company? Simply Wall St. |
07:55AM | Research Report Identifies Cameco, American Equity Investment Life Holding, AG Mortgage Investment Trust, Arena Pharmaceuticals, Mimecast, and Aldeyra Therapeutics with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire |
Jan-25-19 07:38AM | The Daily Biotech Pulse: Intuitive Surgical Earnings, Corbus To Offer Shares, Eton In-Licenses Neurologic Drug Benzinga |
Jan-24-19 08:00PM | United Therapeutics Announces Closing Of License Agreement With Arena Pharmaceuticals For Ralinepag PR Newswire |
08:00PM | Arena Pharmaceuticals Announces Closing of Global License Agreement with United Therapeutics for Ralinepag PR Newswire |
Jan-10-19 07:00AM | Today's Research Reports on Trending Tickers: Arena Pharmaceuticals and ACADIA Pharmaceuticals ACCESSWIRE |
Jan-07-19 08:30AM | Arena Pharmaceuticals Reports Positive Long-Term Data from the Open-Label Extension of the Phase 2 OASIS Trial Evaluating Etrasimod for Treatment of Ulcerative Colitis PR Newswire +6.91% |
Dec-19-18 08:30AM | Arena Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference on January 10 PR Newswire |
Dec-17-18 08:30AM | Arena Pharmaceuticals Appoints Experienced Life Sciences Industry Finance Executive Manmeet S. Soni to Board of Directors PR Newswire -6.72% |
Dec-13-18 10:05PM | Is Arena Pharmaceuticals, Inc. (ARNA) A Good Stock To Buy? Insider Monkey |
06:55AM | Today's Research Reports on Trending Tickers: Arena Pharmaceuticals and China Biologic Products Holdings ACCESSWIRE |
Dec-10-18 12:09PM | What Did Arena Pharmaceuticals Incs (NASDAQ:ARNA) CEO Take Home Last Year? Simply Wall St. |
Dec-06-18 06:50AM | Today's Research Reports on Trending Tickers: Arena Pharmaceuticals and Sarepta Therapeutics ACCESSWIRE |
Nov-27-18 07:35AM | Research Report Identifies Cheniere Energy Partners, LP, Arena Pharmaceuticals, Geron, Keysight Technologies, Grupo Aeroportuario del Centro Norte S.A.B. de C.V, and Casella Waste with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire |
05:00AM | Analysts: Why United Therapeutics has had a streak of licensing deals American City Business Journals |
Nov-26-18 08:30AM | Arena Pharmaceuticals Expands Senior Management Team to Support Commercialization and Medical Affairs PR Newswire |
Nov-23-18 12:58PM | 2 New Small Cap ETFs on the Block Zacks |
Nov-21-18 11:30AM | Opioid Alternatives Could Make Investors Major Gains ACCESSWIRE |
11:21AM | Biotech Stock Roundup: GILD's Drug Wins Nod in China, Arena Up On Licensing Deal Zacks |
Nov-20-18 08:30AM | Arena Pharmaceuticals to Participate in Upcoming Investor Conferences PR Newswire |
Nov-17-18 03:53PM | Edited Transcript of ARNA earnings conference call or presentation 7-Nov-18 9:30pm GMT Thomson Reuters StreetEvents |
08:31AM | My Top 3 Favorite Clinical-Stage Biotech Stocks to Buy Motley Fool |
|
|
|
 |
Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Its investigational clinical programs include ralinepag (APD811), which is in Phase III trial to treat pulmonary arterial hypertension; etrasimod (APD334) for ulcerative colitis, and Crohn's disease, as well as for atopic dermatitis and other indications; and Olorinab (APD371), which is in Phase II trial for the treatment of gastrointestinal pain. It is also developing APD418, a calcium-independent myofilament derepressor for the treatment of decompensated heart failure. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Axovant Sciences GmbH; Outpost Medicine LLC; CY Biotech Company Limited; Boehringer Ingelheim International GmbH; Eisai Co., Ltd.; and Eisai Inc. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California. |
 |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Lisicki Robert | EVP, Chief Commercial Officer | Nov 13 | Sale | 45.83 | 4,429 | 203,000 | 0 | Nov 26 05:44 PM | WOODS RANDALL E | Director | Nov 12 | Option Exercise | 32.50 | 3,046 | 98,995 | 17,276 | Nov 13 08:14 PM | WOODS RANDALL E | Director | Nov 12 | Sale | 46.73 | 3,046 | 142,340 | 14,230 | Nov 13 08:14 PM | SPECTOR STEVEN W | EVP, General Counsel & Sec | Oct 14 | Option Exercise | 0.00 | 6,300 | 0 | 15,990 | Oct 16 08:22 PM | Lisicki Robert | EVP, Chief Commercial Officer | Oct 14 | Option Exercise | 0.00 | 6,300 | 0 | 6,300 | Oct 16 08:21 PM | Klassen Preston | EVP and CMO | Oct 14 | Option Exercise | 0.00 | 6,300 | 0 | 6,300 | Oct 16 08:20 PM | Aurentz Vincent | Executive VP and CBO | Oct 14 | Option Exercise | 0.00 | 9,000 | 0 | 9,000 | Oct 16 08:19 PM | Lind Kevin Robert | Executive VP and CFO | Oct 14 | Option Exercise | 0.00 | 6,300 | 0 | 6,548 | Oct 16 08:18 PM | Munshi Amit | President and CEO | Oct 14 | Option Exercise | 0.00 | 11,700 | 0 | 19,450 | Oct 16 08:17 PM | SPECTOR STEVEN W | EVP, General Counsel & Sec | Sep 10 | Option Exercise | 15.50 | 12,627 | 195,719 | 22,317 | Sep 10 09:03 PM | SPECTOR STEVEN W | EVP, General Counsel & Sec | Sep 10 | Sale | 50.28 | 12,627 | 634,873 | 9,690 | Sep 10 09:03 PM | SPECTOR STEVEN W | EVP, General Counsel & Sec | Sep 09 | Option Exercise | 18.74 | 21,457 | 402,186 | 41,147 | Sep 10 09:03 PM | Aurentz Vincent | Executive VP and CBO | Sep 09 | Option Exercise | 25.25 | 65,000 | 1,641,500 | 65,000 | Sep 10 09:05 PM | Aurentz Vincent | Executive VP and CBO | Sep 09 | Sale | 50.72 | 65,000 | 3,296,700 | 0 | Sep 10 09:05 PM | SPECTOR STEVEN W | EVP, General Counsel & Sec | Sep 09 | Sale | 50.72 | 31,457 | 1,595,515 | 9,690 | Sep 10 09:03 PM | Soni Manmeet Singh | Director | Jun 14 | Sale | 55.89 | 1,217 | 68,022 | 5,087 | Jun 17 06:53 PM | FETZER OLIVER | Director | Jun 14 | Sale | 55.89 | 1,525 | 85,238 | 4,179 | Jun 17 06:41 PM | Dallas Jayson Donald Alexander | Director | Jun 14 | Sale | 55.90 | 1,525 | 85,240 | 4,179 | Jun 17 06:38 PM | Nova Tina Susan | Director | Mar 07 | Option Exercise | 40.10 | 1,200 | 48,120 | 12,676 | Mar 08 06:15 PM | Nova Tina Susan | Director | Mar 07 | Sale | 45.99 | 1,200 | 55,183 | 11,476 | Mar 08 06:15 PM | Klassen Preston | EVP and CMO | Jan 08 | Option Exercise | 15.10 | 3,000 | 45,300 | 3,000 | Jan 08 09:04 PM | Klassen Preston | EVP and CMO | Jan 08 | Sale | 44.00 | 3,000 | 132,000 | 0 | Jan 08 09:04 PM | Klassen Preston | EVP and CMO | Jan 07 | Option Exercise | 15.10 | 16,000 | 241,600 | 16,000 | Jan 08 09:04 PM | Klassen Preston | EVP and CMO | Jan 07 | Sale | 41.69 | 16,000 | 667,066 | 0 | Jan 08 09:04 PM |
|
 |
|
 |
|